CAROLE BEN-MAIMON - President and CEO, Director at Larimar Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
LRMR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by CAROLE BEN-MAIMON since 11 Mar 2025

Holdings reported by CAROLE BEN-MAIMON for Larimar Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 368,276 $1,403,131 $3.81 26 Jan 2026 Direct
Common Stock 31,156 $118,704 $3.81 26 Jan 2026 By Trust
Stock Option (Right to Buy) 600,600 26 Jan 2026 Direct Common Stock

Transactions reported by CAROLE BEN-MAIMON for Larimar Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.